These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 28736841)

  • 1. Outcomes of Blalock-Taussig shunts in current era: A single center experience.
    Sasikumar N; Hermuzi A; Fan CS; Lee KJ; Chaturvedi R; Hickey E; Honjo O; Van Arsdell GS; Caldarone CA; Agarwal A; Benson L
    Congenit Heart Dis; 2017 Dec; 12(6):808-814. PubMed ID: 28736841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-specific outcome analysis of palliation with the modified Blalock-Taussig shunt.
    Bove T; Vandekerckhove K; Panzer J; De Groote K; De Wolf D; François K
    World J Pediatr Congenit Heart Surg; 2015 Jan; 6(1):67-74. PubMed ID: 25548346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified Blalock-Taussig shunt versus ductal stenting for palliation of cardiac lesions with inadequate pulmonary blood flow.
    McMullan DM; Permut LC; Jones TK; Johnston TA; Rubio AE
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):397-401. PubMed ID: 24071469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Reverse Blalock-Taussig shunt": application in single ventricle hybrid palliation.
    Baba K; Honjo O; Chaturvedi R; Lee KJ; Van Arsdell G; Caldarone CA; Benson LN
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):352-7. PubMed ID: 23228402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of multistage palliation of infants with functional single ventricle and heterotaxy syndrome.
    Alsoufi B; McCracken C; Schlosser B; Sachdeva R; Well A; Kogon B; Border W; Kanter K
    J Thorac Cardiovasc Surg; 2016 May; 151(5):1369-77.e2. PubMed ID: 27085618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of systemic to pulmonary artery shunts in patients weighing less than 3 kg: analysis of shunt type, size, and surgical approach.
    Myers JW; Ghanayem NS; Cao Y; Simpson P; Trapp K; Mitchell ME; Tweddell JS; Woods RK
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):672-7. PubMed ID: 24252942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for in-hospital shunt thrombosis and mortality in patients weighing less than 3 kg with functionally univentricular heart undergoing a modified Blalock-Taussig shunt.
    Chittithavorn V; Duangpakdee P; Rergkliang C; Pruekprasert N
    Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):407-413. PubMed ID: 28520941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of palliation with an initial modified Blalock-Taussig shunt in neonates with single ventricle anomalies associated with restrictive pulmonary blood flow.
    Alsoufi B; Gillespie S; Kogon B; Schlosser B; Sachdeva R; Kim D; Clabby M; Kanter K
    Ann Thorac Surg; 2015 May; 99(5):1639-46; discussion 1646-7. PubMed ID: 25818570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of duct stenting and modified Blalock-Taussig shunt in cyanotic congenital heart disease with duct-dependent pulmonary circulation.
    Lekchuensakul S; Somanandana R; Namchaisiri J; Benjacholamas V; Lertsapcharoen P
    Heart Vessels; 2022 May; 37(5):875-883. PubMed ID: 34714397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term survival of hypoplastic left heart syndrome infants: Meta-analysis comparing outcomes from the modified Blalock-Taussig shunt and the right ventricle to pulmonary artery shunt.
    Cao JY; Phan K; Ayer J; Celermajer DS; Winlaw DS
    Int J Cardiol; 2018 Mar; 254():107-116. PubMed ID: 29407078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Single-Centre Retrospective Review of Modified Blalock-Taussig Shunts: A 22-Year Experience.
    Tarca A; Peacock G; McKinnon E; Andrews D; Saundankar J
    Heart Lung Circ; 2023 Mar; 32(3):405-413. PubMed ID: 36621393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anterograde blood flow associated with modified Blalock-Taussig shunt does not modify pulmonary artery growth compared with modified Blalock-Taussig shunt alone.
    Lenoir M; Desnous B; Rahmani B; El Gueddari N; Aries É; El Louali F; Aldebert P; Ovaert C; Metras D; Macé L; Fouilloux V
    Arch Cardiovasc Dis; 2021 Apr; 114(4):268-276. PubMed ID: 33509744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryopreserved Saphenous Vein Compared With PTFE Graft for Use as Modified Blalock-Taussig or Central Shunt in Cyanotic Congenital Heart Disease.
    Kaur R; Bhurtel D; Bielefeld MR; Morales JM; Durham LA
    World J Pediatr Congenit Heart Surg; 2018 Sep; 9(5):509-512. PubMed ID: 30157727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Failure of Systemic-to-Pulmonary Artery Shunts in Biventricular Circulation.
    Vitanova K; Leopold C; Pabst von Ohain J; Wolf C; Beran E; Lange R; Cleuziou J
    Pediatr Cardiol; 2018 Oct; 39(7):1323-1329. PubMed ID: 29756161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duct Stenting Versus Modified Blalock-Taussig Shunt in Neonates With Duct-Dependent Pulmonary Blood Flow: Associations With Clinical Outcomes in a Multicenter National Study.
    Bentham JR; Zava NK; Harrison WJ; Shauq A; Kalantre A; Derrick G; Chen RH; Dhillon R; Taliotis D; Kang SL; Crossland D; Adesokan A; Hermuzi A; Kudumula V; Yong S; Noonan P; Hayes N; Stumper O; Thomson JDR
    Circulation; 2018 Feb; 137(6):581-588. PubMed ID: 29084734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Blalock Taussig shunt: a not-so-simple palliative procedure.
    Dirks V; Prêtre R; Knirsch W; Valsangiacomo Buechel ER; Seifert B; Schweiger M; Hübler M; Dave H
    Eur J Cardiothorac Surg; 2013 Dec; 44(6):1096-102. PubMed ID: 23539419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal Graft Size of Modified Blalock-Taussig Shunt for Biventricular Circulation in Neonates and Small Infants.
    Shibata M; Itatani K; Oka N; Yoshii T; Nakamura Y; Kitamura T; Horai T; Miyaji K
    Int Heart J; 2015; 56(5):533-6. PubMed ID: 26370364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blalock-Taussig Shunt Size: Should it be Based on Body Weight or Target Branch Pulmonary Artery Size?
    Şişli E; Tuncer ON; Şenkaya S; Doğan E; Şahin H; Ayık MF; Atay Y
    Pediatr Cardiol; 2019 Jan; 40(1):38-44. PubMed ID: 30121861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting death and progression towards next stage following modified Blalock-Taussig shunt in neonates.
    Alsoufi B; Gillespie S; Mori M; Clabby M; Kanter K; Kogon B
    Eur J Cardiothorac Surg; 2016 Jul; 50(1):169-77. PubMed ID: 26912652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reasons for Failure of Systemic-to-Pulmonary Artery Shunts in Neonates.
    Vitanova K; Leopold C; von Ohain JP; Wolf C; Beran E; Lange R; Cleuziou J
    Thorac Cardiovasc Surg; 2019 Jan; 67(1):2-7. PubMed ID: 29351695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.